sábado, 16 de diciembre de 2023

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial

https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00216-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanwpc&utm_campaign=update-lanwpc&utm_medium=email&_hsmi=286387350&_hsenc=p2ANqtz-83yTqz-2Lqe_IdcYcUOI13AkZtE9Ow8m1XH_sLMAuEmwrgrG3DtUMQVvb8MW6m9OXnmOy9LlwGYO9NifMaR3g_2fPhGQ&utm_content=286353517&utm_source=hs_email

No hay comentarios: